This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Hemispherx Biopharma Inc (HEB)

AMEX: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 2.16M 803.00K 2.21M 3.10M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 453.00K 897.00K
Other Current Assets 399.00K 358.00K 322.00K 0.00
Total Current Assets 16.51M 18.55M 44.73M 31.79M
Property, Plant & Equipment, Gross 16.94M 16.43M 8.96M 9.78M
Accumulated Depreciation & Depletion 5.00M 4.33M 3.66M 3.02M
Property, Plant & Equipment, Net 11.94M 12.10M 5.29M 6.76M
Intangibles 861.00K 1.08M 1.03M 863.00K
Other Non-Current Assets 134.00K 136.00K 6.64M 4.10M
Total Non-Current Assets 12.93M 13.32M 12.97M 11.73M
Liabilities & Shareholder Equity
Total Assets 29.44M 31.87M 57.70M 43.51M
Accounts Payable 2.08M 1.27M 2.16M 1.68M
Short Term Debt 22.00K 33.00K 46.00K 1.74M
Other Current Liabilities 0.00 0.00 7.05M 0.00
Total Current Liabilities 4.44M 2.53M 12.65M 5.07M
Long Term Debt 0.00 0.00 0.00 380.00K
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 14.00K 295.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 37.00K 350.00K 479.00K
Total Liabilities 4.44M 2.57M 13.00M 5.55M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 25.00M 29.30M 44.70M 37.96M
Common Par 204.00K 168.00K 166.00K 136.00K
Additional Paid In Capital 302.73M 289.56M 288.67M 264.96M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -277.77M -260.32M -244.09M -226.74M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -160.00K -114.00K -43.00K -389.00K
Total Capitalization 25.00M 29.30M 44.70M 38.34M
Total Equity 25.00M 29.30M 44.70M 37.96M
Total Liabilities & Stock Equity 29.44M 31.87M 57.70M 43.51M
Total Common Shares Outstanding 204.00M 168.66M 166.49M 135.64M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 188.29M 167.33M 141.02M 135.43M
Diluted Weighted Shares Outstanding 188.29M 167.33M 141.02M 135.43M
Number of Employees 37 39 34 47
Number of Part-Time Employees 0 0 3 12
HEB News

HEB Hemispherx Biopharma Inc

Analysts Ratings for HEB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET HEB ANALYST REPORT

Brokerage Partners

HEB Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs